Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Phase 1b / 2 Study of Rivoceranib and Trifluridine / Tipiracil for Metastatic Colorectal Cancer

Multiple Cancer Types

Comparing the efficacy of rivoceranib and trifluridine / tipiracil administered individually as monotherapies, as well as a rivocernib plus trifluridine / tipiracil combination therapy in the treatment of mCRC that is unresponsive to traditional chemotherapies.
Colon, Rectal
Eng, Cathy

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: